Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02728804 · ClinicalTrials.gov registry record
S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer
A clinical trial, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- 380
- Enrollment target
NCT02728804 is a clinical trial that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 380 participants.
The verdict
NCT02728804 has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- 380 participants
- Enrollment target
Study Summary
This clinical trial studies the use of the financial impact assessment tool in patients with colorectal cancer that has spread from the primary site to other places in the body. Gathering information about patients with colorectal cancer over time may help doctors better understand the financial impact of cancer and help patients avoid financial problems during treatment.
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2016-06-22 |
| Est. Completion | 2020-11-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02728804
The ClinicalTrials.gov registry entry for NCT02728804 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 380 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.
NCT02728804 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02728804 about?
NCT02728804 is a clinical study titled "S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer". This clinical trial studies the use of the financial impact assessment tool in patients with colorectal cancer that has spread from the primary site to other places in the body. Gathering information about patients with colorectal cancer over time may help doctors better understand the financial imp...
What is the current status of trial NCT02728804?
This trial is currently completed. The enrollment target is 380 participants. The study started on 2016-06-22. Estimated completion is 2020-11-13.
What interventions are being tested in trial NCT02728804?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT02728804?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.